Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Endosc Ultrasound. 2014 Jan;3(1):54-7. doi: 10.4103/2303-9027.121243.
Duodenal varices (DV) although an uncommon cause, are an important cause due to the severe nature of the bleed and associated adverse outcome.
We retrospectively evaluated patients with DV seen at our institution over past 4 years.
A total of 10 patients (nine males; mean age was 35.8 ± 7.68 years) with DV were studied. Five patients had underlying cirrhosis and five had DV because of non-cirrhotic portal hypertension (four patients had extra-hepatic portal venous obstruction and one patient had non-cirrhotic portal fibrosis). Five patients presented with upper gastrointestinal (GI) bleed, whereas in the remaining five patients DV were detected on endoscopy performed for evaluation of portal hypertension. Endoscopy revealed submucosal lesion in nine patients, whereas in one patient an initial endoscopic diagnosis of Dieulafoy's lesion was made. However endoscopic ultrasound (EUS) could clearly identify DV in all patients. Of five patients presenting with upper GI bleed, three had the esophageal varices eradicated and two presented 1(st) time with bleed form DV and did not have esophagogastric varices. All patients with acute upper GI bleed were initially treated with intravenous terlipressin followed by glue (n-butyl cyanoacrylate) injection in 4/5 patients with one patient refusing further endoscopic therapy. The variceal obliteration was documented by EUS in all these four patients and there has been no recurrence of bleed in these four patients over a follow-up period of 4-46 months. The five non-bleeding DV were already on beta- blockers and the same were continued. Two of these five patients succumbed to progressive liver failure with none of these five patients having GI bleed on follow-up.
EUS is a useful investigational modality for evaluating patients with DV and endoscopic injection of glue is an effective therapy for controlling and preventing recurrence of bleed from DV.
十二指肠静脉曲张(DV)虽然少见,但由于其出血的严重性和相关不良后果,是一个重要的病因。
我们回顾性评估了过去 4 年在我们机构就诊的 DV 患者。
共研究了 10 例(9 例男性;平均年龄 35.8±7.68 岁)DV 患者。5 例患者有基础肝硬化,5 例因非肝硬化性门静脉高压症而有 DV(4 例患者有肝外门静脉阻塞,1 例患者有非肝硬化性门静脉纤维化)。5 例患者出现上消化道(GI)出血,而其余 5 例患者是在因门静脉高压症进行内镜检查时发现 DV。内镜显示 9 例患者有黏膜下病变,而 1 例患者最初的内镜诊断为 Dieulafoy 病变。然而,内镜超声(EUS)可以在所有患者中清楚地识别 DV。5 例出现上消化道出血的患者中,3 例食管静脉曲张已被根除,2 例首次出现来自 DV 的出血,且无食管胃静脉曲张。所有急性上消化道出血的患者最初均接受静脉特利加压素治疗,然后在 4/5 例患者中进行胶(n-丁基氰基丙烯酸酯)注射,1 例患者拒绝进一步的内镜治疗。EUS 证实所有这 4 例患者的静脉曲张均已闭塞,在 4-46 个月的随访期间,这 4 例患者均未再发生出血。5 例非出血性 DV 患者已经在使用β受体阻滞剂,且继续使用。这 5 例患者中有 2 例死于进行性肝功能衰竭,且这 5 例患者在随访期间均无 GI 出血。
EUS 是评估 DV 患者的有用的研究方法,内镜下注射胶是控制和预防 DV 出血复发的有效治疗方法。